®
X
GALA
CONFERENCE
®
WHY BLOOM BURTON & CO?
SERVICES
TRANSACTIONS
TEAM
EVENTS
News & Insights
CAREERS
CONTACT
•
M
E
N
U
•
news
April 29, 2016
Bloom Burton's analyst Dave Martin discusses Canadian healthcare risks and opportunities on BNN
Bloom Burton’s analyst Dave Martin discusses Canadian healthcare risks and opportunities on BNN
Click on the image to view the full video.
RELATED NEWS
See All News
APOTEX Health Corp. Announces Closing of Upsized Bought Deal Secondary Offering
BetterLife Pharma Inc. Announces Closing of US$100 Million Public Offering of Common Shares and Pre-Funded Warrants
COSCIENS Acquires Nualtis Corp.
Conavi Medical Corp. Announces Closing of $10M Public Offering
SteriMax Announces Acquisition of Andone Pharmaceuticals, Expanding Presence in Medical Device and Veterinary Markets
Helus Pharma™ Announces US$50 Million Underwritten Offering
Apotex Health Corp. Announces Closing of Upsized Initial Public Offering and Exercise of Over-Allotment Option in Full
PharmaEssentia Expands North American Commercial Footprint with Acquisition of Canadian Partner FORUS Therapeutics
Thiogenesis Closes Oversubscribed Non-Brokered Private Placement for Gross Proceeds of C$9.07 Million
Medicenna Announces Closing of Public Offering of Units Raising CDN$4.44 Million to Support Lead Programs
